Galapagos NV (NASDAQ:GLPG) has been given a consensus rating of “Buy” by the eleven brokerages that are presently covering the firm, MarketBeat reports. Four research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average 1-year price objective among brokerages that have updated their coverage on the stock in the last year is $111.83.

Several research firms have commented on GLPG. Stifel Nicolaus reiterated a “buy” rating and set a $120.00 price objective on shares of Galapagos NV in a research note on Sunday. Cowen and Company reiterated a “buy” rating on shares of Galapagos NV in a research note on Thursday, August 10th. Morgan Stanley reiterated an “overweight” rating and set a $92.00 price objective on shares of Galapagos NV in a research note on Thursday, August 10th. BidaskClub lowered Galapagos NV from a “hold” rating to a “sell” rating in a research note on Saturday, August 5th. Finally, Zacks Investment Research upgraded Galapagos NV from a “sell” rating to a “hold” rating in a research note on Wednesday, October 11th.

TRADEMARK VIOLATION WARNING: “Galapagos NV (GLPG) Given Average Rating of “Buy” by Brokerages” was originally published by American Banking News and is owned by of American Banking News. If you are accessing this article on another domain, it was stolen and republished in violation of US & international copyright law. The correct version of this article can be viewed at https://www.americanbankingnews.com/2017/11/01/galapagos-nv-glpg-given-average-rating-of-buy-by-brokerages.html.

Institutional investors have recently modified their holdings of the company. Advisors Preferred LLC acquired a new position in shares of Galapagos NV during the 3rd quarter worth approximately $105,000. Acadian Asset Management LLC acquired a new position in shares of Galapagos NV during the 2nd quarter worth approximately $166,000. New York State Common Retirement Fund acquired a new position in shares of Galapagos NV during the 2nd quarter worth approximately $166,000. Pacad Investment Ltd. acquired a new position in shares of Galapagos NV during the 2nd quarter worth approximately $168,000. Finally, Karp Capital Management Corp acquired a new position in shares of Galapagos NV during the 1st quarter worth approximately $206,000. Institutional investors and hedge funds own 23.61% of the company’s stock.

Galapagos NV Company Profile

Galapagos NV is a Belgium-based biotechnology company. The Company’s activities are divided into two operating divisions: Research and Development (R & D) and Services. The R & D division is engaged in the discovery and development of small molecules. The Services division, offers target-to-drug discovery products and services to pharmaceutical and biotechnology companies and to patient foundations, encompassing target discovery and validation, screening and drug discovery through to delivery of pre-clinical candidates.

Analyst Recommendations for Galapagos NV (NASDAQ:GLPG)

Receive News & Ratings for Galapagos NV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Galapagos NV and related companies with MarketBeat.com's FREE daily email newsletter.